Transforming Neuroendocrine Cancer Care: The NETRF Research Roadmap
June 25, 2025, 5 p.m. EDT
Discover how we’re revolutionizing neuroendocrine cancer treatment and care and offering new hope for patients. Our world-class research community is already making it happen.
Join us to learn more about:
Breakthroughs in Early Detection – Researchers are investigating ways to identify neuroendocrine cancer earlier and more accurately to transform patient outcomes.
New Therapeutic Innovations – Innovative therapies and new clinical trials are addressing the need for more targeted therapies.
Personalized Medicine and Precision Care – Custom-tailored therapies designed for each patient’s unique genetic profile are changing the neuroendocrine cancer patient journey.
Featured Speakers
Elyse Gellerman, CEO, NETRF
Anna Greene, PhD, Director of Research, NETRF
Susan Harrington, Chief Development Officer, NETRF
Neil Renwick, MBChB, PhD, MCTS, FCAP, Queen’s University
Jennifer Eads, MD, University of Pennsylvania
Chris Heaphy, PhD, Boston University